WGS
NASDAQ HealthcareGeneDx Holdings Corp. - Class A Common Stock
Diagnostics & Research
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
๐ Market Data
| Price | $90.11 |
|---|---|
| Volume | 875,969 |
| Market Cap | 2.67B |
| Beta | 2.010 |
| RSI (14-Day) | 52.8 |
| 200-Day MA | $81.08 |
| 50-Day MA | $78.93 |
| 52-Week High | $170.87 |
| 52-Week Low | $32.21 |
| Forward P/E | 76.64 |
| Price / Book | 10.93 |
๐ฏ Investment Strategy Scores
WGS scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (85/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (8/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find WGS in your text
Paste any article, transcript, or post โ the tool will extract WGS and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-24.